105 related articles for article (PubMed ID: 29674181)
1. High glucose forces a positive feedback loop connecting ErbB4 expression and mTOR/S6K pathway to aggravate the formation of tau hyperphosphorylation in differentiated SH-SY5Y cells.
Nie SD; Li X; Tang CE; Min FY; Shi XJ; Wu LY; Zhou SL; Chen Z; Wu J; Song T; Dai ZJ; Zheng J; Liu JJ; Wang S
Neurobiol Aging; 2018 Jul; 67():171-180. PubMed ID: 29674181
[TBL] [Abstract][Full Text] [Related]
2. High glucose induces formation of tau hyperphosphorylation via Cav-1-mTOR pathway: A potential molecular mechanism for diabetes-induced cognitive dysfunction.
Wu J; Zhou SL; Pi LH; Shi XJ; Ma LR; Chen Z; Qu ML; Li X; Nie SD; Liao DF; Pei JJ; Wang S
Oncotarget; 2017 Jun; 8(25):40843-40856. PubMed ID: 28489581
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin Attenuated Zinc-Induced Tau Phosphorylation and Oxidative Stress in Rats: Involvement of Dual mTOR/p70S6K and Nrf2/HO-1 Pathways.
Lai C; Chen Z; Ding Y; Chen Q; Su S; Liu H; Ni R; Tang Z
Front Immunol; 2022; 13():782434. PubMed ID: 35197970
[TBL] [Abstract][Full Text] [Related]
4. Beta estradiol and norepinephrine treatment of differentiated SH-SY5Y cells enhances tau phosphorylation at (Ser
Majd S; Majd Z; Koblar S; Power J
Mol Cell Neurosci; 2018 Apr; 88():201-211. PubMed ID: 29427776
[TBL] [Abstract][Full Text] [Related]
5. Activation of mTOR signaling leads to orthopedic surgery-induced cognitive decline in mice through β-amyloid accumulation and tau phosphorylation.
Shen W; Lu K; Wang J; Wu A; Yue Y
Mol Med Rep; 2016 Oct; 14(4):3925-34. PubMed ID: 27599409
[TBL] [Abstract][Full Text] [Related]
6. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells.
Fang CX; Yang X; Sreejayan N; Ren J
Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100
[TBL] [Abstract][Full Text] [Related]
7. mTOR-mediated hyperphosphorylation of tau in the hippocampus is involved in cognitive deficits in streptozotocin-induced diabetic mice.
Wang S; Zhou SL; Min FY; Ma JJ; Shi XJ; Bereczki E; Wu J
Metab Brain Dis; 2014 Sep; 29(3):729-36. PubMed ID: 24682776
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
Chen S; An FM; Yin L; Liu AR; Yin DK; Yao WB; Gao XD
Neuroscience; 2014 Jan; 256():137-46. PubMed ID: 24183963
[TBL] [Abstract][Full Text] [Related]
9. Seipin deletion in mice enhances phosphorylation and aggregation of tau protein through reduced neuronal PPARγ and insulin resistance.
Chang H; Di T; Wang Y; Zeng X; Li G; Wan Q; Yu W; Chen L
Neurobiol Dis; 2019 Jul; 127():350-361. PubMed ID: 30910747
[TBL] [Abstract][Full Text] [Related]
10. High-glucose induces tau hyperphosphorylation through activation of TLR9-P38MAPK pathway.
Sun Y; Xiao Q; Luo C; Zhao Y; Pu D; Zhao K; Chen J; Wang M; Liao Z
Exp Cell Res; 2017 Oct; 359(2):312-318. PubMed ID: 28803064
[TBL] [Abstract][Full Text] [Related]
11. High glucose up-regulates Semaphorin 3A expression via the mTOR signaling pathway in keratinocytes: A potential mechanism and therapeutic target for diabetic small fiber neuropathy.
Wu LY; Li M; Qu ML; Li X; Pi LH; Chen Z; Zhou SL; Yi XQ; Shi XJ; Wu J; Wang S
Mol Cell Endocrinol; 2018 Sep; 472():107-116. PubMed ID: 29203371
[TBL] [Abstract][Full Text] [Related]
12. mTOR and tau phosphorylated proteins in the hippocampal tissue of rats with type 2 diabetes and Alzheimer's disease.
Ma YQ; Wu DK; Liu JK
Mol Med Rep; 2013 Feb; 7(2):623-7. PubMed ID: 23165862
[TBL] [Abstract][Full Text] [Related]
13. MALAT1 Regulated mTOR-Mediated Tau Hyperphosphorylation by Acting as a ceRNA of miR144 in Hippocampus Cells Exposed to High Glucose.
Lu C; Zhao Y; Cao Y; Liu L; Wu S; Li D; Liu S; Xiao S; Wei Y; Li X
Clin Interv Aging; 2021; 16():1185-1191. PubMed ID: 34188461
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
15. Modulation of oxidative stress and tau phosphorylation by the mTOR activator phosphatidic acid in SH-SY5Y cells.
Taga M; Mouton-Liger F; Paquet C; Hugon J
FEBS Lett; 2011 Jun; 585(12):1801-6. PubMed ID: 21510936
[TBL] [Abstract][Full Text] [Related]
16. Wogonin increases β-amyloid clearance and inhibits tau phosphorylation via inhibition of mammalian target of rapamycin: potential drug to treat Alzheimer's disease.
Zhu Y; Wang J
Neurol Sci; 2015 Jul; 36(7):1181-8. PubMed ID: 25596147
[TBL] [Abstract][Full Text] [Related]
17. S6K Promotes Dopaminergic Neuronal Differentiation Through PI3K/Akt/mTOR-Dependent Signaling Pathways in Human Neural Stem Cells.
Lee JE; Lim MS; Park JH; Park CH; Koh HC
Mol Neurobiol; 2016 Aug; 53(6):3771-3782. PubMed ID: 26143260
[TBL] [Abstract][Full Text] [Related]
18. FTO is involved in Alzheimer's disease by targeting TSC1-mTOR-Tau signaling.
Li H; Ren Y; Mao K; Hua F; Yang Y; Wei N; Yue C; Li D; Zhang H
Biochem Biophys Res Commun; 2018 Mar; 498(1):234-239. PubMed ID: 29501742
[TBL] [Abstract][Full Text] [Related]
19. Neuregulin-1β promotes glucose uptake via PI3K/Akt in neonatal rat cardiomyocytes.
Pentassuglia L; Heim P; Lebboukh S; Morandi C; Xu L; Brink M
Am J Physiol Endocrinol Metab; 2016 May; 310(9):E782-94. PubMed ID: 26979522
[TBL] [Abstract][Full Text] [Related]
20. Activation of mTOR signaling mediates the increased expression of AChE in high glucose condition: in vitro and in vivo evidences.
Liu YW; Zhang L; Li Y; Cheng YQ; Zhu X; Zhang F; Yin XX
Mol Neurobiol; 2016 Sep; 53(7):4972-80. PubMed ID: 26374551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
